Cipla Limited Patent litigation record

Company 81 cases

81 cases on record naming Cipla Limited: 4 as claimant, 77 as respondent. Each row links to that case’s full docket record.

Profile this company in Eureka
Litigation indexPatsnap Litigation Data··Docket source: PACER

81 cases on record

Cases on record
81
As claimant
4
As respondent
77
Patents held
Not recorded
Core tech
A61K31/56 · A61K47/26 · A61K47/18 · A61K47/10 · A01N45/00 · A61P11/06 · A61P27/14 · A61P37/08 · A61K31/573 · A61K47/38 · C07C229/00 · C07B57/00 · C07C213/00 · C07C59/255
Case no.PartiesRoleCourtFiledDurationOutcome
2:26-cv-03796 Ars Pharmaceuticals Operations, Inc. v. Cipla Limited Defendant D.N.J. 10 Apr 2026 88 d Case Consolidated
1:25-cv-01420 Vifor Fresenius Medical Care Renal Pharma, Ltd. v. Cipla Limited Defendant D. Del. 21 Nov 2025 217 d Consent Judgment
2:25-cv-16422 American Regent, Inc. v. Cipla Limited Defendant D.N.J. 9 Oct 2025 43 d Case Consolidated
1:25-cv-01236 HQ Specialty Pharma, Corp. v. Cipla Limited Defendant D. Del. 7 Oct 2025 225 d Consent Judgment
1:25-cv-00929 Mitsubishi Chemical Holdings Corporation v. Cipla Limited Defendant D. Del. 24 Jul 2025 342 d Case Transferred
2:25-cv-05709 Fennec Pharmaceuticals, Inc. v. Cipla Limited Defendant D.N.J. 27 May 2025 48 d Case Consolidated
1:25-cv-00216 Novartis, AG v. Cipla Limited Defendant D. Del. 21 Feb 2025 18 d Dismissed without Prejudice
1:25-cv-00186 Novartis, AG v. Cipla Limited Defendant D. Del. 14 Feb 2025 234 d Voluntary dismissal
2:25-cv-01147 Celgene, Corp. v. Cipla Limited Defendant D.N.J. 10 Feb 2025 219 d Consent Judgment
2:24-cv-11112 American Regent, Inc. v. Cipla Limited Defendant D.N.J. 13 Dec 2024 21 d Case Consolidated
1:24-cv-01333 Astellas Pharma, Inc. v. Cipla Limited Defendant D. Del. 6 Dec 2024 579 d Dismissed with Prejudice
1:24-cv-01287 Astellas Pharma, Inc. v. Cipla Limited Defendant D. Del. 22 Nov 2024 469 d Dismissed with Prejudice
1:24-cv-10213 Salix Pharmaceuticals, Inc. v. Cipla Limited Defendant D.N.J. 1 Nov 2024 354 d Case Settled
2:24-cv-09691 Teva Pharmaceutical Industries, Ltd. v. Cipla Limited Defendant D.N.J. 9 Oct 2024 117 d Case Consolidated
2:24-cv-08435 American Regent, Inc. v. Cipla Limited Defendant D.N.J. 13 Aug 2024 581 d Consent Judgment
2:24-cv-07796 American Regent, Inc. v. Cipla Limited Defendant D.N.J. 16 Jul 2024 128 d Case Consolidated
2:24-cv-07162 Teva Pharmaceutical Industries, Ltd. v. Cipla Limited Defendant D.N.J. 21 Jun 2024 273 d Case Consolidated
1:24-cv-00565 Exelixis, Inc. v. Cipla Limited Defendant D. Del. 9 May 2024 61 d Dismissed without Prejudice
2:24-cv-05856 Teva Pharmaceutical Industries, Ltd. v. Cipla Limited Defendant D.N.J. 6 May 2024 319 d Case Consolidated
2:24-cv-00909 Teva Branded Pharmaceutical Products R&d LLC v. Cipla Limited Defendant D.N.J. 16 Feb 2024 580 d Dismissed without Prejudice
1:23-cv-01480 Gilead Sciences, Inc. v. Cipla Limited Defendant D. Del. 29 Dec 2023 647 d Case Consolidated
1:23-cv-01196 Bayer AG v. Cipla Limited Defendant D. Del. 20 Oct 2023 782 d Voluntary dismissal
1:23-cv-01157 Hikma Pharmaceuticals USA, Inc. v. Cipla Limited Defendant D. Del. 13 Oct 2023 475 d Dismissed without Prejudice
23-2241 Cipla Limited v. Teva Pharmaceutical Industries, Ltd. Plaintiff Fed. Cir. 4 Aug 2023 557 d Case Remanded
1:23-cv-00759 Mitsubishi Chemical Holdings Corporation v. Cipla Limited Defendant D. Del. 12 Jul 2023 1072 d Case Transferred
1:23-cv-00389 Actelion Pharmaceuticals US, Inc. v. Cipla Limited Defendant D. Del. 6 Apr 2023 502 d Consent Judgment
1:23-cv-00287 Exelixis, Inc. v. Cipla Limited Defendant D. Del. 16 Mar 2023 481 d Case Dismissed
2:23-cv-00123 Fennec Pharmaceuticals, Inc. v. Cipla Limited Defendant D.N.J. 10 Jan 2023 1175 d Consent Judgment
1:22-cv-00162 Acerta Pharma B.V. v. Cipla Limited Defendant D. Del. 4 Feb 2022 860 d Consent Judgment
1:21-cv-01229 UCB Pharma, Gmbh v. Cipla Limited Defendant D. Del. 26 Aug 2021 1735 d Judgment on the merits for Plaintiff
2:20-cv-14890 Teva Branded Pharmaceutical Products R&D, Inc. v. Cipla Limited Defendant D.N.J. 23 Oct 2020 77 d Other
1:20-cv-01393 Pfizer, Inc. v. Cipla, Ltd. Defendant D. Del. 16 Oct 2020 199 d Likely Settlement
2021-1055 GlaxoSmithKline Consumer Healthcare Holdings (US) LLC v. Cipla Limited Defendant Fed. Cir. 16 Oct 2020 47 d Closed
2021-1016 GlaxoSmithKline Consumer Healthcare Holdings (US) LLC v. Cipla Limited Defendant Fed. Cir. 5 Oct 2020 58 d Closed
2021-1017 GlaxoSmithKline Consumer Healthcare Holdings (US) LLC v. Cipla Limited Defendant Fed. Cir. 5 Oct 2020 58 d Closed
2021-1018 GlaxoSmithKline Consumer Healthcare Holdings (US) LLC v. Cipla Limited Defendant Fed. Cir. 5 Oct 2020 58 d Closed
2:20-cv-10172 Teva Pharmaceutical Industries, Ltd. v. Cipla Limited Defendant D.N.J. 7 Aug 2020 1056 d Injunction Granted
1:20-cv-00977 ViiV Healthcare, Co. v. Cipla Limited Defendant D. Del. 22 Jul 2020 965 d Consent Judgment
2:20-cv-07759 Celgene Corporation v. CIPLA Limited Defendant D.N.J. 24 Jun 2020 173 d Other
2020-1875 Onyx Therapeutics, Inc. v. CIPLA Limited Defendant Fed. Cir. 10 Jun 2020 271 d Closed
1:19-cv-02210 Biogen International, GmbH v. Cipla Limited Defendant D. Del. 27 Nov 2019 215 d Voluntary dismissal
2:19-cv-20810 Cipla Limited v. Novartis, AG Plaintiff D.N.J. 26 Nov 2019 71 d Voluntary dismissal
1:19-cv-02085 ViiV Healthcare Company v. Cipla Limited Defendant D. Del. 4 Nov 2019 882 d Closed
1:19-cv-01494 Boehringer-Ingelheim v. Cipla Limited Defendant D. Del. 9 Aug 2019 1495 d Injunction Granted
2:19-cv-14731 Celgene Corporation v. CIPLA Limited Defendant D.N.J. 3 Jul 2019 530 d Other
3:19-cv-12920 Cubist Pharmaceuticals, LLC v. Cipla Limited Defendant D.N.J. 24 May 2019 516 d Likely Settlement
1:19-cv-00219 Genentech, Inc. v. Cipla Limited Defendant D. Del. 1 Feb 2019 1026 d Procedural Outcome
3:19-cv-00988 Valeant Pharmaceuticals North America, LLC v. Cipla Limited Defendant D.N.J. 23 Jan 2019 82 d Other
1:18-cv-01838 Genzyme Corporation v. Cipla, Ltd. Defendant D. Del. 20 Nov 2018 322 d Other
1:18-cv-01789 Boehringer-Ingelheim v. Cipla Limited Defendant D. Del. 13 Nov 2018 1764 d Injunction Granted
3:18-cv-14225 Valeant Pharmaceuticals North America, LLC v. Cipla Limited Defendant D.N.J. 24 Sep 2018 203 d Other
3:18-cv-11262 Celgene Corporation v. Cipla Limited Defendant D.N.J. 29 Jun 2018 1041 d Likely Settlement
1:18-cv-00844 Astellas Pharma, Inc. v. Cipla, Ltd. Defendant D. Del. 5 Jun 2018 79 d Likely Settlement
1:18-cv-01671 Cipla, Ltd. v. Eli Lilly and Co. Plaintiff S.D. Ind. 1 Jun 2018 96 d Likely Settlement
1:18-cv-00753 H. Lundbeck A/S v. CIPLA Limited Defendant D. Del. 17 May 2018 706 d Other
2:18-cv-08964 Celgene Corporation v. CIPLA Limited Defendant D.N.J. 8 May 2018 762 d Stayed
1:18-cv-00598 Onyx Therapeutics, Inc. v. Cipla Limited Defendant D. Del. 20 Apr 2018 762 d Judgment on the Merits
1:18-cv-00247 Pharmacyclics, LLC v. Cipla Limited Defendant D. Del. 12 Feb 2018 1176 d Procedural Outcome
1:18-cv-00147 H. Lundbeck A/S v. CIPLA Limited Defendant D. Del. 25 Jan 2018 818 d Other
1:17-cv-01741 ViiV Healthcare Company v. Cipla Limited Defendant D. Del. 4 Dec 2017 1247 d Other
1:17-cv-01670 ViiV Healthcare Company v. Cipla Limited Defendant D. Del. 17 Nov 2017 1264 d Other
1:17-cv-01631 AbbVie, Inc. v. Cipla, Ltd. Defendant D. Del. 10 Nov 2017 146 d Likely Settlement
1:17-cv-01244 Alcon Research, Ltd. v. Cipla, Ltd. Defendant D. Del. 31 Aug 2017 377 d Likely Settlement
2:17-cv-06163 Celgene Corporation v. CIPLA Limited Defendant D.N.J. 15 Aug 2017 1028 d Stayed
1:17-cv-00851 Biogen International, GmbH v. CIPLA Limited Defendant D. Del. 28 Jun 2017 1182 d Judgment on the Merits
2:16-cv-09074 Abraxis Bioscience, LLC v. Cipla, Ltd. Defendant D.N.J. 7 Dec 2016 671 d Other
1:16-cv-01005 Eli Lilly & Company v. CIPLA Limited Defendant D. Del. 28 Oct 2016 87 d Voluntary dismissal
1:16-cv-02911 Eli Lilly & Company v. CIPLA Limited Defendant S.D. Ind. 26 Oct 2016 195 d Procedural Outcome
1:16-cv-00988 Onyx Therapeutics, Inc. v. Cipla Limited Defendant D. Del. 24 Oct 2016 2311 d Judgment on the merits for Plaintiff
1:16-cv-00880 Amgen, Inc. v. CIPLA Limited Defendant D. Del. 29 Sep 2016 522 d Other
1:16-cv-01208 Eli Lilly & Company v. Cipla, Ltd. Defendant E.D. Va. 22 Sep 2016 292 d Other
1:15-cv-00424 Cipla, Ltd. v. Sunovion Pharmaceuticals, Inc. Plaintiff D. Del. 26 May 2015 1050 d Likely Settlement
1:15-cv-00307 Janssen Products, LP v. Cipla Limited Defendant D. Del. 10 Apr 2015 24 d Likely Settlement
2:15-cv-02571 The United States Department Of Health And Human Services v. Cipla Limited Defendant D.N.J. 10 Apr 2015 188 d Likely Settlement
2:15-cv-02549 Janssen Products, LP v. Cipla Limited Defendant D.N.J. 9 Apr 2015 26 d Likely Settlement
2:15-cv-00176 Data Carriers, LLC v. CIPLA Limited Defendant E.D. Tex. 9 Feb 2015 401 d Likely Settlement
1:14-cv-01056 Janssen Products, LP v. Cipla Limited Defendant D. Del. 15 Aug 2014 262 d Other
2:14-cv-05135 The United States Department Of Health And Human Services v. Cipla Limited Defendant D.N.J. 15 Aug 2014 426 d Likely Settlement
2:14-cv-05093 Janssen Products, LP v. Cipla, Ltd. Defendant D.N.J. 13 Aug 2014 1477 d Likely Settlement
1:14-cv-00427 Helsinn Healthcare, S.A. v. Cipla Limited Defendant D. Del. 7 Apr 2014 568 d Other
1:14-cv-00131 Alcon Research, Ltd. v. CIPLA Limited Defendant S.D. Ind. 29 Jan 2014 428 d Likely Settlement
Source: Patsnap Litigation Data. Cases naming Cipla Limited in the current snapshot. Run this in Eureka
Patsnap Eureka

See what Cipla is protecting

Portfolio, claim scope and where its coverage is thin. Every answer cites the records behind it.

Analyse this portfolio
10,000 free credits to start

About this summary. This page summarises the litigation records within the coverage and snapshot dates stated here. Counts describe records in that dataset and do not, by themselves, establish the conduct, litigation success or legal position of any person or organisation.

Docket data has limits. Records are drawn from a snapshot and may lag the live docket. Sealed filings, amended complaints, counterclaims and post-closure motions may not be reflected. Party names, attorney names and firm affiliations are reproduced as recorded and may contain omissions. Where a field is absent from the record, this page marks it as not recorded rather than inferring a value.

No characterisation of the parties or the outcome. This page reports what the record contains. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, that any settlement occurred, or that any party prevailed. The filing of a claim is not a court finding, and a docket marked “closed” does not by itself establish infringement, validity, settlement or a decision on the merits.

No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.

Third-party names and marks. Party, attorney, judge and company names appear for identification only. Company names may be trademarks of their owners; their appearance does not, by itself, imply affiliation with or endorsement by Patsnap.

Corrections and privacy requests. To report an inaccurate record or attribution, use the “Report an incorrect record” link on this page. For requests concerning your personal information, including, where applicable, the rights to access, rectify, erase, restrict or object to processing, use the “Privacy request” link. We assess requests under applicable law. See our Privacy Policy for details of this processing.

Help us improve

Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.